Company developing a new gene therapy products for the treatment of rare diseases.

The company is focused on the use of bacteriocins and anti-microbial therapies.

Cancer diagnostics.

Design and manufacture accelerator graphical cards for datacenters.

Oxvalue.ai offers a useful new approach for appraising technology, and an important guide for decision-making in technology investment, transfer and commercialisation.

Digital health company focused on neurodegenerative diseases.

Digital CBTe software.

A proprietary multi-omics discovery platform to resolve RNA-centric mechanisms in rare and chronic diseases.

Provides advanced insights on global information operations, data flows, and public understanding of critical issues.

Provides the tools you need to measure, report, and act on nature risks and opportunities, aligned with global regulations and standards.

Design oligonucleotide drugs that can activate expression of specific genes using a novel gene regulatory mechanism.

Aim to deliver rapid diagnosis of inherited blood disorders, infectious diseases and early-stage cancer in sub-Saharan Africa.

High-speed Vision, LIDAR and IMU tracking/odometry and mapping.

Revolutionising the production of Fluorochemicals. A highly innovative, cost-effective and sustainable technology that removes the hazards of traditional fluorinating processes and supply chain.

Help customers obtain high-purity metals from their waste or process streams in a simple & highly profitable manor and achieve sustainability goals by removing toxic metals from wastewater.

Platform to promote critical thought on India and British Indians.

To improve the ESG outcomes of publicly traded corporations by enhancing the efficacy of shareholder ownership rights.

Optical neural networks.

To develop new methodologies for single cell genomics.

To develop and commercialise a rapid non-lab based diagnostic test for viral infections, with the first focus on Covid19.